Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, June 21 '25)

Image
By G.M.

 


    Ann Intern Med

  1. BILINSKI A, Emanuel N, Ciaranello A
    Sins of Omission: Model-Based Estimates of the Health Effects of Excluding Pregnant Participants From Randomized Controlled Trials.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-00689.
    PubMed         Abstract available

  2. YEK C, Mancera AG, Diao G, Walker M, et al
    Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals : Retrospective Cohort Study of Trends and Risk Factors.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-03078.
    PubMed         Abstract available


    Cell

  3. PEKAR JE, Lytras S, Ghafari M, Magee AF, et al
    The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2.
    Cell. 2025;188:3167-3183.
    PubMed         Abstract available


    Drug Saf

  4. ABATE A, Poncato E, Barbieri MA, Powell G, et al
    Off-the-Shelf Large Language Models for Causality Assessment of Individual Case Safety Reports: A Proof-of-Concept with COVID-19 Vaccines.
    Drug Saf. 2025;48:805-820.
    PubMed         Abstract available


    J Infect

  5. BREUER J, Drysdale M, Walker J, Han J, et al
    Monitoring the Emergence of Resistance With Sotrovimab in Immunocompromised Patients With COVID-19: LUNAR Study.
    J Infect. 2025 May 19:106510. doi: 10.1016/j.jinf.2025.106510.
    PubMed         Abstract available


    J Infect Dis

  6. CHUN A, Bautista-Castillo A, Osuna I, Nasto K, et al
    Distinguishing Multisystem Inflammatory Syndrome in Children From Typhus Using Artificial Intelligence: MIS-C Versus Endemic Typhus (AI-MET).
    J Infect Dis. 2025;231:931-939.
    PubMed         Abstract available


    J Virol

  7. LUGANO D, Mwangi K, Mware B, Kibet G, et al
    Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.
    J Virol. 2025 May 6:e0048225. doi: 10.1128/jvi.00482.
    PubMed         Abstract available

  8. KONDO T, Suzuki R, Yajima H, Kawahara S, et al
    Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.
    J Virol. 2025 May 12:e0054325. doi: 10.1128/jvi.00543.
    PubMed         Abstract available

  9. FURUSAWA Y, Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y, et al
    The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.
    J Virol. 2025 May 13:e0065625. doi: 10.1128/jvi.00656.
    PubMed         Abstract available

  10. BEAN DJ, Liang YM, Avila F, He X, et al
    Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.
    J Virol. 2025 May 19:e0055025. doi: 10.1128/jvi.00550.
    PubMed         Abstract available

  11. SONG Q, Yang H, Zhu H, Hu Y, et al
    Hydrophobic residue substitutions enhance the stability and in vivo immunogenicity of respiratory syncytial virus fusion protein.
    J Virol. 2025;99:e0008725.
    PubMed         Abstract available

  12. ESPARZA M, El Zahed SS, Karakus U, Niederstrasser H, et al
    Contrasting interferon-mediated antiviral responses in human lung adenocarcinoma cells.
    J Virol. 2025;99:e0046925.
    PubMed         Abstract available


    PLoS One

  13. LEPLAA HJ, Tonjes JA, Bouterse M, Soppe KFB, et al
    Applying qualitative methods to experimental designs: A tutorial for the behavioral sciences.
    PLoS One. 2025;20:e0324936.
    PubMed         Abstract available

  14. FEDDERN L, Kaba I, Fischer HT, Geurts B, et al
    Inter-agency collaboration to support the COVID-19 response and maintain malaria services in Guinea and Sierra Leone: A social network analysis.
    PLoS One. 2025;20:e0325597.
    PubMed         Abstract available

  15. MHD YUNIN NS, Tan TL
    National Early Warning Score 2 (NEWS2) as a prognostic tool for adult patients in emergency department: A retrospective observational study.
    PLoS One. 2025;20:e0326058.
    PubMed         Abstract available

  16. ARREGUI-GALLEGO B, Orts-Cortes MI, Moreno-Casbas MT, Abad-Corpa E, et al
    Factors modulating the impact of the COVID-19 pandemic on posttraumatic stress symptomatology of the Spanish healthcare workers: A cohort study.
    PLoS One. 2025;20:e0323777.
    PubMed         Abstract available

  17. NOFZINGER TB, Huang TT, Lingat CER, Amonkar GM, et al
    Vaccine fatigue and influenza vaccination trends across Pre-, Peri-, and Post-COVID-19 periods in the United States using epic's cosmos database.
    PLoS One. 2025;20:e0326098.
    PubMed         Abstract available

  18. MORTENSON WB, Esfandiari E, Mohammadi S, Sakakibara B, et al
    Pandemic-related experiences of older adults and people with disabilities.
    PLoS One. 2025;20:e0325306.
    PubMed         Abstract available

  19. SHI B, Yu L, Yang Q, Zhang N, et al
    Spatio-temporal heterogeneity of metro ridership under major epidemic conditions.
    PLoS One. 2025;20:e0326114.
    PubMed         Abstract available

  20. ALKHOURI NB, Fisher V, Michel I, O'Connor C, et al
    The impact of historical redlining policies on community composition and the COVID-19 pandemic in Boston.
    PLoS One. 2025;20:e0324020.
    PubMed         Abstract available

  21. ZHANG Y, Li W, Dong S
    Does the registration system reform reduce the finance sector's risk spillover effect in China's stock market-Causal inference based on dual machine learning.
    PLoS One. 2025;20:e0326607.
    PubMed         Abstract available


  22. Retraction: Clinical impact of monocyte distribution width and neutrophil-to-lymphocyte ratio for distinguishing COVID-19 and influenza from other upper respiratory tract infections: A pilot study.
    PLoS One. 2025;20:e0326523.
    PubMed        

  23. FLYNT S, Cho GY, Koscinski B, Accorso C, et al
    A one-arm pilot trial of a telehealth CBT-based group intervention targeting transdiagnostic risk for emotional distress.
    PLoS One. 2025;20:e0303131.
    PubMed         Abstract available

  24. SUN L
    On China's image constructed from western news coverage of China's humanitarian aid.
    PLoS One. 2025;20:e0326214.
    PubMed         Abstract available

  25. MICHAELIDES P, Sarkadi S
    Covid-19 in hospitals: Studying influencing factors through agent-based modelling.
    PLoS One. 2025;20:e0326350.
    PubMed         Abstract available

  26. KANYAMA T, Masunaga A, Kawahara T, Morita H, et al
    Natural soap is clinically effective and less toxic and more biodegradable in aquatic organisms and human skin cells than synthetic detergents.
    PLoS One. 2025;20:e0324842.
    PubMed         Abstract available

  27. MUNROE ES, Grandits GA, Hyzy RC, Prescott HC, et al
    Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
    PLoS One. 2025;20:e0325561.
    PubMed         Abstract available

  28. ACCETTA AF, Medeiros DM, Diniz Ribeiro MP, Cardoso SW, et al
    Tracheostomy in COVID-19: A retrospective cohort study of outcomes and mortality predictors in a specialized infectious disease hospital in Brazil.
    PLoS One. 2025;20:e0326531.
    PubMed         Abstract available

  29. MAGABLEH GM, Al-Dwairi AF, Alhamouri A
    Improving the performance of the coffee supply chain using integrating fuzzy MCDM and simulation methods.
    PLoS One. 2025;20:e0326581.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  30. GE X, Hou Y
    Social influence during public crises: Weekly dynamics and adaptive patterns of conformity to the collective following the COVID-19 outbreak.
    Proc Natl Acad Sci U S A. 2025;122:e2500008122.
    PubMed         Abstract available


    Vaccine

  31. PUENTE-MASSAGUER E, Vasilev K, Krammer F
    Combination of recombinant neuraminidase with cHA-based inactivated split vaccines improves the breadth of cross-reactivity and protection against influenza viruses in mice.
    Vaccine. 2025;61:127388.
    PubMed         Abstract available

  32. HANSEN BT, Dahl J, Greve-Isdahl M, Winje BA, et al
    Low and inequitable influenza and COVID-19 vaccination coverage among pregnant women in Norway: Nationwide population-based cohort study.
    Vaccine. 2025;61:127386.
    PubMed         Abstract available


    Virology

  33. TABYNOV K, Kuanyshbek A, Zharmambet K, Yelchibayeva L, et al
    Evaluation of commercial vaccines for efficacy and transmission control against the emergent H5N8 (clade 2.3.4.4b) avian influenza virus in Kazakhstan.
    Virology. 2025;610:110601.
    PubMed         Abstract available


    Virus Res

  34. SHEN CH, Tsai HP, Chou CC, Yeh CS, et al
    Plant MIR2911 in honeysuckle is effective against SARS-CoV-2 variant.
    Virus Res. 2025;357:199583.
    PubMed         Abstract available

  35. MATSUZAKI Y, Sugawara K, Kadowaki Y, Kidoguchi Y, et al
    Characterization of Antigenically Dominant Regions in the Hemagglutinin Protein of B/Victoria-Lineage Influenza B Virus Using Monoclonal Antibody Escape Mutants.
    Virus Res. 2025 Jun 14:199598. doi: 10.1016/j.virusres.2025.199598.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

Stability of #influenza viruses in the #milk of #cows and #sheep

By G.M.
Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...
Post a Comment
Read more »

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

By G.M.
Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____
Post a Comment
Read more »